In conclusion, our experiment found that both apatinib and an HSD not only elevated blood pressure in a gastric cancer mouse model through the RhoA/ROCK signaling pathway but also promoted vascular remodeling and left ventricular hypertrophy. The gene discussed is RHOA; the disease is left ventricular hypertrophy.